Skip to main content
. 2021 Feb 1;99(2):269–276. [Article in French]

Table 3. Clinical features of patients with attributable mortality to multidrug-resistant bacteremia .

N/Age/sex Hematologic diseases Type of HSCT Date of bacteremia/HSCT Neutrophil counts/ Duration of neutropenia Concomitant Colonization with the same MDR strain GVHD MDR species Antibiotherapy Molecule, appropriate (time form bacteremia) Concomitant infection Date of death/ bacteremia Outcome Date of death/ HSCT
1st line 2nd line
1/7/M AA Allogenic PBSC transplant Day+83 10 190 days Yes Yes K. IMP+AK N, ,o (day0) CS+FOS, yes (day1) - Day+2 Septic shock Day+85
2/16/F AA Allogenic BM transplant Day+2 0 179 days Yes Yes P. aer R (B-lac, CIP, Gen) IMP+CIP, no (day1) CS+FOS, yes (day4) - Day+15 Septic shock Day+17
3/33/M AA Allogenic BM transplant Day-1 0 62 days Yes No K. TYG+PTZ, no (day1) FOS, yes (day4) - Day+15 ARDS Day+14
4/38/M AML allogenic BM transplant Day+154 380 10 days Yes No K. CS+FOS, yes (day0) IMP+AKN, yes (day3) - Day+8 Septic shock Day+162
5/30/M Myeloma autologous HSCT Day+11 0 19 days No No P. aer R (B-lac, FOS, CIP, Gen) IMP+AKN, no (day0) CS, yes (day3) - Day+13² Septic shock Day+24
6/56/F NHL autologous HSCT Day0 700 7days No No s. mar (ESBL) PTZ+AKN, no (day0) IMP+CS, yes (day4) K, p and E. cloacae bacteremia Day+8 Septic shock Day+8